SNPX: Kapitalisasi marang bathi Neurotrope
Synaptogenix, Inc. (SNPX) focuses on discovering dementia therapies by studying synapse regeneration and conducting trials of Bryostatin-1. The quotes provided below are fixed at 0.00. Simultaneously, Inertia is developing anti-neurodegeneration agents, which will ensure stable demand throughout the duration of patent ownership. However, the business is currently only consuming capital, lacking operational income sources to generate profit.
Rincian analitis perusahaan Neurotrope (SNPX)
- nilai pasar lan prakiraan target analis:
- informasi kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data liabilitas lan likuiditas perusahaan:
Utang Agregat marang Ekuitas Synaptogenix, Inc.|SNPX - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Synaptogenix, Inc|SNPX - Utang perusahaan|Utang-utang marang nilai buku Synaptogenix, Inc.|SNPX - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Synaptogenix|Likuiditas darurat synaptogen.com
- rincian asil keuangan lan kelipatan valuasi:
SNPX - Bathi resik perusahaan|Prakiraan bathi resik Synaptogenix, Inc.|SNPX - Pangali P/E|Kapitalisasi marang proyeksi bathi Synaptogenix Inc.|SNPX - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Synaptogenix, Inc.|SNPX - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Synaptogenix|SNPX - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan synaptogen.com|SNPX - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Synaptogenix, Inc.
Analisis komprehensif perusahaan:SNPX (synaptogen.com)
Analyzing the assets of Synaptogenix, Inc. (SNPX) requires a precise assessment of market expectations. The company's fundamental P/E multiple relates the current share price to annual net income, determining the price per unit of profit. An increase in this indicator signals investor confidence in the future success of biopharmaceutical developments. The effective implementation of ESG standards and bioethics reduces operational risks, supporting investment attractiveness. Valuation stability confirms the capital's resilience to external shocks.
Pesaing wigati
biogen.com (BIIB) - Periode bali modal bisnis|Koefisien rega marang bathi NBIX (Neurocrine Biosciences, Inc.)|RGC - Kapitalisasi marang bathi|Rasio rega marang bathi Axsome Therapeutics Inc AXSM|ACAD: Pangali rega marang bathi|Xenon Pharmaceuticals - Pangali P/E|VKTX - Pangali P/E|Supernus (SUPN) - Rasio rega marang bathi|Kapitalisasi marang bathi resik CPRX (Catalyst Pharma)|Koefisien rega marang bathi DNLI|HRMY (Harmony Corp) - Rasio rega pasar marang bathi resik|Rasio rega marang bathi Biohaven Ltd. (BHVN)|AMLX - Kapitalisasi marang bathi|Pangali P/E TRVI (Trevi Therapeutics, Inc.)|Rasio kapitalisasi marang bathi resik Praxis Precision Medicines Inc|Anavex Corp - Pangali P/E|Kapitalisasi marang bathi CeriBell EEG|prothena.com (PRTA) - Rasio rega marang bathi|Pangali rega marang bathi ALEC|ANNX (Annexon) - Pangali P/E|Omeros Corp. (OMER) - Periode bali modal bisnis|Koefisien rega marang bathi NGNE (Neurogene Corp)|AC Immune Inc - Pangali rega marang bathi|Voyager Therapeutics - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik NMRA|Scilex - Pangali P/E|Periode bali modal bisnis Tevogen Bio Holdings Inc. TVGN|alphacognition.com (ACOG) - Rasio rega marang bathi|Pangali rega marang bathi CGTX|IKT (Inhibikase Therapeutics) - Pangali P/E|Koefisien rega marang bathi cassavasciences.com (SAVA)|Koefisien rega marang bathi ASRT (Assertio Holdings, Inc.)|Periode bali modal bisnis coyatherapeutics.com|Rasio rega marang bathi Vistagen VTGN|Periode bali modal bisnis Ovid Therapeutics Inc (OVID)|ABOS - Rasio rega marang bathi|CRVO (cervomed.com) - Pangali rega marang bathi|alteritytherapeutics.com (ATHE) - Rasio rega marang bathi|Kapitalisasi marang bathi resik CLNN (Clene)|Koefisien rega marang bathi PEPG|Pangali rega marang bathi JUNS (Jupiter Neurosciences, Inc.)|Rasio rega marang bathi Relmada Therapeutics (RLMD)|annovisbio.com - Pangali rega marang bathi|Pangali P/E GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Kapitalisasi marang bathi|KLTO: Koefisien rega marang bathi|NRSN - Pangali P/E|Reviva Pharmaceuticals (RVPH) - Rasio rega marang bathi|MetaVia - Nilai perusahaan marang bathi resik|Rasio rega marang bathi NeurAxis|Kapitalisasi marang bathi Helius Medical Technologies Inc. HSDT|Rasio rega marang bathi Passage Bio, Inc. (PASG)|Periode bali modal bisnis bionomics.com.au|Minerva Neurosciences - Koefisien rega marang bathi|athira.com (ATHA) - Kapitalisasi marang bathi|ADXN - Rasio rega marang bathi|ALZN (Alzamend Neuro, Inc.) - Pangali rega marang bathi|CYCN: Pangali P/E|Protagenic Therapeutics, Inc. (PTIX) - Pangali P/E|Rasio rega marang bathi Pasithea Therapeutics Corp|Cortigent Medical - Kapitalisasi marang bathi resik|Koefisien rega marang bathi ATXI (Avenue Therapeutics, Inc.)|Rasio rega pasar marang bathi resik BCLI|Rasio rega marang bathi Cara Therapeutics, Inc CARA|Chromocell (CHRO) - Kapitalisasi marang bathi|Eliem - Pangali P/E|Rasio kapitalisasi marang bathi resik Intra-Cellular Therapies (ITCI)|LBPH: Pangali P/E|Kapitalisasi marang bathi Marinus Pharmaceuticals Inc (MRNS)|Rasio rega marang bathi NKGen|Pangali rega marang bathi NRBO (NeuroBo Pharma)|Pangali P/E SAGE|Periode bali modal bisnis trevena.com|Vigil Neuroscience, Inc. - Koefisien rega marang bathi|WENA: Pangali rega marang bathi|CERE: Koefisien rega marang bathi
